SARS-CoV-2 Main Protease Inhibitor High-Throughput Screen

被引：0
作者：
Delgado, Renee [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX USA
来源：
JOURNAL OF BIOLOGICAL CHEMISTRY | 2024年 / 300卷 / 03期
关键词：
Mpro (main protease); high-throughput screening; drug discovery; SARS-CoV-2;
D O I：
10.1016/j.jbc.2024.106070
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1217
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 50 条
  • [21] SARS-CoV-2 RNA-dependent RNA polymerase as a target for high-throughput drug screening
    Wu, Jiahui
    Chen, Zhiqiang
    Han, Xue
    Chen, Qiaoqiao
    Wang, Yintao
    Feng, Tingting
    FUTURE VIROLOGY, 2023, : 51 - 62
  • [22] High-throughput screening assays for SARS-CoV-2 drug development: Current status and future directions
    Xu, Tuan
    Zheng, Wei
    Huang, Ruili
    DRUG DISCOVERY TODAY, 2021, 26 (10) : 2439 - 2444
  • [23] Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors
    Cardoso, Wesley B.
    Mendanha, Sebastiao A.
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1225
  • [24] Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening
    Sanachai, Kamonpan
    Somboon, Tuanjai
    Wilasluck, Patcharin
    Deetanya, Peerapon
    Wolschann, Peter
    Langer, Thierry
    Lee, Vannajan Sanghiran
    Wangkanont, Kittikhun
    Rungrotmongkol, Thanyada
    Hannongbua, Supot
    PLOS ONE, 2022, 17 (06):
  • [25] Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro)
    Sayed, Ahmed M.
    Alhadrami, Hani A.
    El-Gendy, Ahmed O.
    Shamikh, Yara, I
    Belbahri, Lassaad
    Hassan, Hossam M.
    Abdelmohsen, Usama Ramadan
    Rateb, Mostafa E.
    MICROORGANISMS, 2020, 8 (07) : 1 - 17
  • [26] Ensemble docking based virtual screening of SARS-CoV-2 main protease inhibitors
    Fomina, Anastasia D.
    Uvarova, Victoria I.
    Kozlovskaya, Liubov I.
    Palyulin, Vladimir A.
    Osolodkin, Dmitry I.
    Ishmukhametov, Aydar A.
    MOLECULAR INFORMATICS, 2024, 43 (08)
  • [27] Fragment-based in silico design of SARS-CoV-2 main protease inhibitors
    Ahmad, Sarfraz
    Mirza, Muhammad Usman
    Kee, Lee Yean
    Nazir, Mamoona
    Rahman, Noorsaadah Abdul
    Trant, John F.
    Abdullah, Iskandar
    CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 98 (04) : 604 - 619
  • [28] Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: A virtual screening study
    Bolelli, Kayhan
    Ertan-Bolelli, Tugba
    Unsalan, Ozan
    Altunayar-Unsalan, Cisem
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1228 (1228)
  • [29] Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study
    Refaey, Rana H.
    El-Ashrey, Mohamed K.
    Nissan, Yassin M.
    VIROLOGY, 2021, 554 : 48 - 54
  • [30] An ISG15-Based High-Throughput Screening Assay for Identification and Characterization of SARS-CoV-2 Inhibitors Targeting Papain-like Protease
    Samrat, Subodh Kumar
    Kumar, Prashant
    Liu, Yuchen
    Chen, Ke
    Lee, Hyun
    Li, Zhong
    Chen, Yin
    Li, Hongmin
    VIRUSES-BASEL, 2024, 16 (08):
12345